Research Article
Prognostic Factors of Mortality among Adult Patients on Antiretroviral Therapy in India: A Hospital Based Retrospective Cohort Study
Table 2
Distribution of various characteristics before and after start of antiretroviral therapy (ART) among patients.
| Characteristics before starting ART | | | Characteristics after starting ART | | |
| | Number | Percentage | | Number | Percentage |
| Functional status (n=285) | | | Functional status (n=240) | | |
| Ambulatory | 51 | 17.9 | Ambulatory | 1 | 0.4 |
| Bedridden | 6 | 2.1 | Bedridden | 1 | 0.4 |
| Working | 228 | 80.0 | Working | 238 | 99.2 |
| Pattern of substance usage (n=285) | | | Pattern of substance usage (n=285) | | |
| Tobacco chewing | 13 | 4.6 | Tobacco chewing | 14 | 4.9 |
| Smoking | 32 | 11.2 | Smoking | 15 | 5.3 |
| Alcohol consumption | 62 | 21.7 | Alcohol consumption | 22 | 7.7 |
| Opportunistic infections present (n=285) | | | Opportunistic infections present (n=285) | | |
| Extra pulmonary tuberculosis | 34 | 11.9 | Pulmonary tuberculosis | 15 | 5.3 |
| Pulmonary tuberculosis | 28 | 9.8 | Extra pulmonary tuberculosis | 9 | 3.2 |
| Candidiasis | 5 | 1.7 | Cytomegalovirus infection | 2 | 0.7 |
| Pneumocystis jiroveci pneumonia | 4 | 1.4 | Toxoplasmosis | 2 | 0.7 |
| Cryptococcal infections | 2 | 0.7 | Others | 2 | 0.7 |
| Toxoplasmosis | 2 | 0.7 | | | |
| Others | 3 | 1.0 | | | |
| BMI (Kg per sq.mtrs) of patients before starting ART (n=257) | | | BMI of patients after 60 months of starting ART (n=67) | | |
| Under weight | 87 | 33.9 | Under weight | 19 | 28.4 |
| Normal weight | 112 | 43.6 | Normal weight | 23 | 34.3 |
| Over weight | 25 | 9.7 | Over weight | 16 | 23.9 |
| Obese | 33 | 12.8 | Obese | 9 | 13.4 |
| Clinical staging of HIV patients before starting ART (n=285) | | | Clinical staging of HIV patients after 60 months of starting ART (n=90) | | |
| Stage 1 | 172 | 60.3 | Stage 1 | 75 | 83.3 |
| Stage 2 | 18 | 6.3 | Stage 2 | 6 | 6.7 |
| Stage 3 | 27 | 9.5 | Stage 3 | 5 | 5.6 |
| Stage 4 | 68 | 23.9 | Stage 4 | 4 | 4.4 |
| Mean CD4 count (cells/cu.mm) before starting ART (n=285) | 381.4±235.9 | | Mean CD4 count (cells/cu.mm) after 60 months of starting ART (n=62) | 596±216.7 | |
|
|
Cytomegalovirus infection 1, recurrent respiratory infections 1, and cellulitis 1. Cryptococcal infections 1 and skin rashes 1. |